Edwards Lifesciences Corporation (EW) /
The cash flow of Edwards Lifesciences Corporation over the past 10 years
Chart Edwards Lifesciences Corporation: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Edwards Lifesciences Corporation's operating cash flow was $1.6B and its capital expenditures $260.2M, leaving free cash flow of $1.33B. Free cash flow was above zero in all 10 years shown. It ranged from $289.9M in fiscal 2024 to $1.41B in fiscal 2021. Capital expenditures were highest in fiscal 2020, at $407M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.6B | $260.2M | $1.33B |
| 2024ended Dec 31, 2024 | $542.3M | $252.4M | $289.9M |
| 2023ended Dec 31, 2023 | $895.8M | $253M | $642.8M |
| 2022ended Dec 31, 2022 | $1.22B | $244.6M | $973.6M |
| 2021ended Dec 31, 2021 | $1.73B | $325.8M | $1.41B |
| 2020ended Dec 31, 2020 | $1.05B | $407M | $647.3M |
| 2019ended Dec 31, 2019 | $1.18B | $254.4M | $928.5M |
| 2018ended Dec 31, 2018 | $926.7M | $238.7M | $688M |
| 2017ended Dec 31, 2017 | $1B | $168.1M | $832.6M |
| 2016ended Dec 31, 2016 | $704.4M | $176.1M | $528.3M |
Fiscal years as Edwards Lifesciences Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Edwards Lifesciences Corporation
- The revenue of Edwards Lifesciences Corporation
- The profitability of Edwards Lifesciences Corporation
- The debt of Edwards Lifesciences Corporation
- All of Edwards Lifesciences Corporation's financials, charted
Companies of a similar size
Not investment advice. This page shows what Edwards Lifesciences Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.